Company: LIMN
Filing Date: 2025-06-24
Form Type: S-1
Source: 0001410578-25-001432
Chunk: 337

Company: Liminatus Pharma, Inc.
Filing Date: 2025-06-24
Form: S-1
Chunk 337
---
 Company had not commenced any operations. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on the investments held in the Trust Account.

The Company’s CODM has been identified as the Chief Executive Officer, who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company is a single segment entity. When evaluating the Company’s performance and making key decisions regarding resource allocation the CODM reviews several key metrics, which include the following:

| ​                                          | ​ 
 ​ | ​ |                 ​ 
 December 31, 2024 | ​ | ​ |                 ​ 
 December 31, 2023 |
|:-------------------------------------------|:--|:--|------------------:|:--|:--|------------------:|
| Cash                                       | ​ | $ |            65,343 | ​ | $ |           156,425 |
| Cash and Investments held in Trust Account | ​ | $ |         2,016,274 | ​ | $ |         4,291,332 |

| ​                                                                  
 ​                                                                  | ​ 
 ​ 
 ​ | ​                  
 For the Year Ended |                 ​ 
 December 31, 2024 | ​ 
 ​ | ​                  
 For the Year Ended |                 ​ 
 December 31, 2023 |
|:-------------------------------------------------------------------|:--|:-------------------|------------------:|:--|:-------------------|------------------:|
| Other general and administrative expenses                          | ​ | $                  |         1,909,768 | ​ | $                  |         1,231,012 |
| Professional services fees in connection with Business Combination | ​ | ​                  |           996,551 | ​ | ​                  |         1,071,934 |
| Total operating expenses                                           | ​ | $                  |         2,906,319 | ​ | $                  |         2,302,946 |
| ​                                                                  | ​ | ​                  |                 ​ | ​ | ​                  |                 ​ |
| Interest income on investments held in Trust Account               | ​ | $                  |           137,717 | ​ | $                  |           553,641 |

The key measures of segment profit or loss reviewed by the CODM are interest earned on investments held in Trust Account and operating and formation costs. The CODM reviews interest